0220-5244 : Verbascum Thapsus 200 [Kp_c]/200[kp_c] Oral Pellet
| NDC: | 0220-5244 |
| Labeler: | Boiron |
| Product Type: | Human OTC Drug |
| Drug Name: | Verbascum Thapsus |
| Dosage Form: | Oral Pellet |
| Rev. Date: |
NDC Package Codes:
- 0220-5244-41: 200 [KP_C] IN 1 TUBE (0220‑5244‑41)
Active Ingredients:
- Verbascum Thapsus
Dosage Strength:
- 200 [kp_C]/200[kp_C]
Related Products:
Based on records with the same trade name.- 0220-5242 Verbascum Thapsus 6 [Hp_c]/6[hp_c] Oral Pellet by Boiron
- 0220-5243 Verbascum Thapsus 30 [Hp_c]/30[hp_c] Oral Pellet by Boiron
- 15631-0457 Verbascum Thapsus 1 [hp_x]/1 Oral Pellet by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc
- 37662-1630 Verbascum Thapsus 6 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-1631 Verbascum Thapsus 12 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-1632 Verbascum Thapsus 30 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-1633 Verbascum Thapsus 100 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-1634 Verbascum Thapsus 200 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-1635 Verbascum Thapsus 500 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-1636 Verbascum Thapsus 1 [Hp_m]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 37662-1637 Verbascum Thapsus 1 [Hp_q]/1 Oral Pellet by Hahnemann Laboratories, Inc.
- 68428-698 Verbascum Thapsus 30 [Hp_c]/1 Oral Pellet by Washington Homeopathic Products
- 71919-707 Verbascum Thapsus 30 [Hp_c]/Ml Oral Liquid by Washington Homeopathic Products
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 0220-5243Next: 0220-5254 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
